SERENA COBB: Open Payments
NPI 1396286431 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,552 in 125 payments from 31 companies in 2025. Trend: 2023 $1,494 · 2024 $2,305 · 2025 $2,552
Food & beverage: $2,552
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $301 |
| ABBVIE INC. | 23 | $287 |
| AstraZeneca Pharmaceuticals LP | 7 | $216 |
| Vanda Pharmaceuticals Inc. | 9 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $155 |
| Amgen Inc. | 9 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $127 |
| Novo Nordisk Inc | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Exact Sciences Corporation | 4 | $81 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, FARXIGA, JARDIANCE, PREVNAR 20, ELIQUIS, REPATHA.
Industry payments across SC — which companies pay providers there.
